Comment on FDA takes only drug for premature birth off the market

On Thursday, the US Food and Drug Administration announced its final decision to withdraw its approval of Makena, a drug approved more than a decade ago to reduce the risk of preterm birth. The FDA says that the drug is not effective and that the benefits of taking it do not outweigh the risk.